Who invested in Novoron Bioscience

One round we have observed, with the 3 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Pharma

Raised 10 months ago

Funding summaryUpdated 26 Oct 2026

$2.5Mraised across 1 round since 2026, from 1 source

Latest round: Grant, $2.5MJan 2026
Investors: 3

See who backed them

The rounds

Jan 2026
Grant$2.5M
Source recorded

Founders and team

From the SEC filings it signed: 2 on the team.

Shawn GahrExecutive Officer, Directori
Travis StilesExecutive Officer, Directori

On the board, as filediMichael Goguen

Everyone who backed them

National Institutes of HealthGovernment1round

Backstage CapitalVC firm1round

National Institute on AgingVC firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Novoron Bioscience as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.

Phase Two VenturesVC firmPer its own site

Quick answers about Novoron Bioscience

Who invested in Novoron Bioscience?

Novoron Bioscience's investors include National Institutes of Health, Backstage Capital and National Institute on Aging.

How much has Novoron Bioscience raised?

Novoron Bioscience has raised $2.5M across 1 round since 2026.

When did Novoron Bioscience last raise?

Novoron Bioscience's most recent round was a Grant of $2.5M in Jan 2026.

What was Novoron Bioscience's biggest round?

Its most recent round, $2.5M in Jan 2026, is also its largest on record.

Who backed Novoron Bioscience first?

Novoron Bioscience's first round on record, in Jan 2026, was backed by National Institutes of Health, Backstage Capital and National Institute on Aging.